Yahoo Finanzen CEO Mark Baum Acquires 9,000 Shares of Harrow Inc (HROW)
Mark Baum, Chief Executive Officer of Harrow Inc (NASDAQ:HROW), has increased his stake in the company by purchasing 9,000 shares on March 22, 2024, according to a recent SEC Filing. This transaction has been part of a series of buys from the insider over the past year, bringing Mark Baum's total purchased shares to 22,300, with no recorded sales in the same period.
Harrow Inc specializes in the development, production, and commercialization of pharmaceutical products. The company's focus is on providing innovative solutions in the healthcare sector, particularly in the areas of ophthalmology and injectable products.
Insider buying and selling activities are closely monitored by investors as they can provide insights into a company's internal perspective. An insider purchase can suggest confidence in the company's future prospects, while insider sales may indicate the opposite. The recent acquisition by the insider of Harrow Inc aligns with a broader trend of insider confidence, as evidenced by the 7 insider buys over the past year, with no insider sales reported in the same timeframe.
On the valuation front, Harrow Inc's shares were trading at $11.59 on the day of the insider's purchase, giving the company a market cap of $406.67 million. The stock's price-to-GF-Value ratio stands at 0.69, with a GuruFocus Value of $16.75, indicating that the stock is currently categorized as a Possible Value Trap, Think Twice according to the GF Value metric.
The GF Value is a proprietary valuation metric used by GuruFocus, which is derived from a combination of historical trading multiples, an adjustment factor based on the company's historical performance, and future business performance estimates provided by Morningstar analysts.
The insider trend image above reflects the recent insider transactions at Harrow Inc, providing a visual representation of the buying and selling activities by company insiders.
The GF Value image provides a visual guide to the stock's current valuation in relation to its intrinsic value, as estimated by GuruFocus.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
